Lifordi Immunotherapeutics, Inc.
PrivateLast Round
Series A
Extension
Nov 18, 2025
Total Funding Raised
$112M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lifordi Immunotherapeutics, Inc. operates in Healthcare & Life Sciences and is based in Burlington, Massachusetts. Its latest recorded funding round was a Series A Extension round in November 2025.
Lifordi Immunotherapeutics, Inc. is a biotechnology company that develops targeted antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lifordi Immunotherapeutics, Inc. Comparables
Compare Lifordi Immunotherapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Santa Ana Bio | 79% | |
| AbbVie | 76% | |
| AbolerIS Pharma | 71% |
For institutional investors. Book with your work email.
Lifordi Immunotherapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 18, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lifordi Immunotherapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 5AM Ventures | Series A, Series A Extension |
| ARCH Venture Partners | Series A, Series A Extension |
| Sanofi Ventures | Series A Extension |
| Atlas Venture | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors increased 59% MoM, reaching 12.4K.
- Jan 24, 2026
Monthly visitors increased 1486% MoM, reaching 7.8K.
For institutional investors. Book with your work email.
Lifordi Immunotherapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lifordi Immunotherapeutics, Inc.'s valuation, stock price, and market status.
Is Lifordi Immunotherapeutics, Inc. a public or private company?
Lifordi Immunotherapeutics, Inc. is a private company.
What is the current stock price of Lifordi Immunotherapeutics, Inc.?
Lifordi Immunotherapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Lifordi Immunotherapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lifordi Immunotherapeutics, Inc. worth (valuation)?
Valuation information for Lifordi Immunotherapeutics, Inc. is not publicly available.
Can I buy Lifordi Immunotherapeutics, Inc. stock?
Lifordi Immunotherapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lifordi Immunotherapeutics, Inc.'s last funding round?
Lifordi Immunotherapeutics, Inc.'s most recent funding round was Series A Extension on November 18, 2025.
Who are the main investors in Lifordi Immunotherapeutics, Inc.?
Key investors in Lifordi Immunotherapeutics, Inc. include 5AM Ventures, ARCH Venture Partners, Sanofi Ventures, Atlas Venture.
Will Lifordi Immunotherapeutics, Inc. IPO soon?
No public IPO plans have been announced for Lifordi Immunotherapeutics, Inc..
How can I track Lifordi Immunotherapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Lifordi Immunotherapeutics, Inc.'s shares on secondary markets.